{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:07:01Z","timestamp":1779084421139,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, &amp; Immunity - Health"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbih.2019.100035","type":"journal-article","created":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T21:57:46Z","timestamp":1578261466000},"page":"100035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Somatic pain associated with initiation of interferon-alpha (IFN-\u03b1) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study"],"prefix":"10.1016","volume":"2","author":[{"given":"Chih Ying","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Wei","family":"Guu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill Yi-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Chung","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shing-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-0928","authenticated-orcid":false,"given":"Jane Pei-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2019.100035_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cld.2017.03.007","article-title":"Chronic hepatitis C virus infection and depression","volume":"21","author":"Adinolfi","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbih.2019.100035_bib2","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1097\/j.pain.0000000000001595","article-title":"Brain moderators supporting the relationship between depressive mood and pain","volume":"160","author":"Adler-Neal","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.bbih.2019.100035_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0006-3223(93)90041-B","article-title":"Pain perception threshold in major depression","volume":"34","author":"Adler","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0034-1371008","article-title":"Interferon-combination strategies for the treatment of chronic hepatitis C","volume":"34","author":"Aronsohn","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbih.2019.100035_bib5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbih.2019.100035_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jad.2016.06.030","article-title":"The impact of somatic symptoms on the course of major depressive disorder","volume":"205","author":"Bekhuis","year":"2016","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.bbih.2019.100035_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpsychores.2014.11.007","article-title":"Differential associations of specific depressive and anxiety disorders with somatic symptoms","volume":"78","author":"Bekhuis","year":"2015","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbih.2019.100035_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/1028415X.2015.1123378","article-title":"Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection","volume":"20","author":"Chang","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbih.2019.100035_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4306\/pi.2017.14.3.314","article-title":"Association of changes in mood status and psychosocial well-being with depression during interferon-based treatment for hepatitis C","volume":"14","author":"Choi","year":"2017","journal-title":"Psychiatr. Investig."},{"key":"10.1016\/j.bbih.2019.100035_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychores.2012.01.009","article-title":"The epidemiology of multiple somatic symptoms","volume":"72","author":"Creed","year":"2012","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","article-title":"The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells","volume":"107","author":"Denicoff","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbih.2019.100035_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4088\/JCP.09m05282blu","article-title":"Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"72","author":"Diez-Quevedo","year":"2011","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2014.02.005","article-title":"The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?","volume":"105","author":"Feld","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib15","first-page":"221","article-title":"The association of chronic pain and suicide","volume":"4","author":"Fishbain","year":"1999","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-8278(01)00280-X","article-title":"Emotional distress in chronic hepatitis C patients not receiving antiviral therapy","volume":"36","author":"Fontana","year":"2002","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbih.2019.100035_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF02598007","article-title":"The relationship of presenting physical complaints to depressive symptoms in primary care patients","volume":"7","author":"Gerber","year":"1992","journal-title":"J.\u00a0Gen. Intern. Med."},{"key":"10.1016\/j.bbih.2019.100035_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0163-8343(02)00239-6","article-title":"Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study","volume":"25","author":"Horikawa","year":"2003","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160450","article-title":"Anti-viral therapy and decreased sexual desire in patients with chronic hepatitis C","volume":"11","author":"Hsiao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2019.100035_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpsychores.2014.07.020","article-title":"A\u00a0longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C","volume":"78","author":"Huckans","year":"2015","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1176\/appi.psy.44.5.359","article-title":"Gender and symptoms in primary care practices","volume":"44","author":"Jackson","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.bbih.2019.100035_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000285676","article-title":"Significance of somatic complaints in patients suffering from psychotic depression","volume":"11","author":"Jones","year":"1963","journal-title":"Acta Psychother. Psychosom."},{"key":"10.1016\/j.bbih.2019.100035_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31887\/DCNS.2006.8.2\/hpkapfhammer","article-title":"Somatic symptoms in depression","volume":"8","author":"Kapfhammer","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbih.2019.100035_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1176\/appi.psy.44.6.471","article-title":"Somatic symptoms in primary care: etiology and outcome","volume":"44","author":"Khan","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.bbih.2019.100035_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbih.2019.100035_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mpr.140","article-title":"Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management","volume":"12","author":"Kroenke","year":"2003","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib27","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/archinte.1993.00410210102011","article-title":"Symptoms in the community: prevalence, classification, and psychiatric comorbidity","volume":"153","author":"Kroenke","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbih.2019.100035_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archfami.3.9.774","article-title":"Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment","volume":"3","author":"Kroenke","year":"1994","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/j.bbih.2019.100035_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-3956(94)90023-X","article-title":"Pain perception in psychiatric disorders: a review of the literature","volume":"28","author":"Lautenbacher","year":"1994","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","article-title":"The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI","volume":"12","author":"Lecrubier","year":"1997","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib31","article-title":"Pro- and anti-inflammatory cytokine associations with major depression in cancer patients","author":"Li","year":"2016","journal-title":"Psycho Oncol."},{"key":"10.1016\/j.bbih.2019.100035_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychores.2012.10.012","article-title":"Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study","volume":"74","author":"Loftis","year":"2013","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.bbih.2019.100035_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/107999001300177457","article-title":"Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C","volume":"21","author":"Malaguarnera","year":"2001","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.bbih.2019.100035_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2013.01.020","article-title":"Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?","volume":"149","author":"Novick","year":"2013","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.bbih.2019.100035_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.60.1.39","article-title":"Using chronic pain to predict depressive morbidity in the general population","volume":"60","author":"Ohayon","year":"2003","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.bbih.2019.100035_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-017-0674-5","article-title":"The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: a mixed-methods study","volume":"19","author":"Pettersson","year":"2018","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.bbih.2019.100035_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbih.2019.100035_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2007.03316.x","article-title":"Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C","volume":"25","author":"Raison","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbih.2019.100035_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement","volume":"57","author":"Schaefer","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbih.2019.100035_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon alpha (IFNalpha) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.genhosppsych.2012.11.001","article-title":"Psychological and behavioral variables associated with the somatic symptom severity of general hospital outpatients in China","volume":"35","author":"Schaefert","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini international neuropsychiatric interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.bbih.2019.100035_bib44","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00127-012-0540-7","article-title":"The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression","volume":"48","author":"Silverstein","year":"2013","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.bbih.2019.100035_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000198167","article-title":"Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a \u2019mind-body interface\u2019?","volume":"17","author":"Su","year":"2009","journal-title":"Neurosignals"},{"key":"10.1016\/j.bbih.2019.100035_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7603\/s40681-015-0021-x","article-title":"Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-alpha-induced depression","volume":"5","author":"Su","year":"2015","journal-title":"Biomedicine"},{"key":"10.1016\/j.bbih.2019.100035_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbi.2019.04.032","article-title":"Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder","volume":"80","author":"Su","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2019.100035_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-5-28","article-title":"The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study","volume":"5","author":"Tamayo","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib50","first-page":"167","article-title":"The importance of somatic symptoms in depression in primary care","volume":"7","author":"Tylee","year":"2005","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib51","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.4088\/JCP.13r08800","article-title":"Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"75","author":"Udina","year":"2014","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib52","first-page":"39","article-title":"Mood and cognitive side effects of interferon-alpha therapy","volume":"25","author":"Valentine","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbih.2019.100035_bib53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/07357909509024923","article-title":"Treatment of neurotoxic side effects of interferon-alpha with naltrexone","volume":"13","author":"Valentine","year":"1995","journal-title":"Canc. Invest."},{"key":"10.1016\/j.bbih.2019.100035_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/S0007125000298474","article-title":"The relationship between pain and depression","volume":"Suppl","author":"Von Korff","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbih.2019.100035_bib55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1520-6394(1998)7:4<188::AID-DA7>3.0.CO;2-6","article-title":"Hepatitis C and depression","volume":"7","author":"Yates","year":"1998","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbih.2019.100035_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.genhosppsych.2011.09.005","article-title":"Association of somatic symptoms with depression and anxiety in clinical patients of general hospitals in Guangzhou, China","volume":"34","author":"Zhu","year":"2012","journal-title":"Gen. Hosp. Psychiatry"}],"container-title":["Brain, Behavior, &amp; Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354619300365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354619300365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:22:31Z","timestamp":1762986151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354619300365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":56,"alternative-id":["S2666354619300365"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2019.100035","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic pain associated with initiation of interferon-alpha (IFN-\u03b1) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2019.100035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100035"}}